-
and increase in this neurotransmitter is associated with psychosis
dopamine
-
an increase inthis neurotransmitter is associated with decreased anxiety
GABA
-
a decrease in this neurotransmitter is associated with depression
serotonin
-
category of drug used to treat schizophrinia
antipsychotic agents
-
category of drugs used to treat bipolar disorders
mood stabilizers
-
uses include treatment of psychosis, hiccups, and nausea and vomiting
phenothiazines
-
used to treat both positive and negative symptoms of schizophrinia
atypical antipsychotic agents
-
term used to describe unusual body movements which are a s/e of antipsychotic agents
extrapyramidal symptoms
-
s/e of antipsychotic agents producing fever and hypertension
neuroleptic malignant syndrome
-
act to enhance levels of GABA to decrease anxiety
benzodiazepines
-
act to suppress subcortical areas of CNS to relieve anxiety
antihistamines
-
main s/e of benzodiazepines and antihistamines
-
-
anxiolytic which has very few s/e
buspirone (BuSpar)
-
act by blocking uptake of norepinephrine and serotonin
TCA's
-
act by inhibiting monoamine oxidase and increasing neurotransmitters
MAOI's
-
adverse reaction to MAOI's
hypertensive crisis
-
act by blocking reuptake of serotonin into nerve terminal
SSRI's
-
acts to treat bipolar disorder by altering Na and K ion transport
lithium
-
act to treat bipolar disorder by stabilizing brain cell membranes
anticonvulsants
-
s/e of Paeudoparkinsonism antipsychotic agents:
tremors, shuffling gait, rigidity
-
s/e of Tardive dyskinesia antipsychotic agents:
tongue protrusion, chewing motions
-
s/s of lithium toxicity
trembling, slurred speech, oliguria, confusion
-
common s/e of psychotropic agents
orthostatic hypotension
|
|
